Lexaria Bioscience (LEXX) vs Exicure (XCUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lexaria Bioscience is the larger company by market cap ($7.0 million vs $6.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LEXX | XCUR |
|---|---|---|
| Share price | $3.32 | $1.05 |
| Market cap | $6.99M | $6.87M |
| 1-day change | -1.19% | +3.96% |
| EPS (TTM) | $-5.10 | $-1.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $21.60 | $9.48 |
| 52-week low | $2.77 | $0.936 |
| Distance from 52-week high | -84.63% | -88.92% |
| Analyst consensus | none | — |
| Avg. price target upside | +2384.94% | — |
| Average volume | 62.36K | 393.66K |
| Shares outstanding | 2.11M | 6.55M |
| Employees | 7 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lexaria Bioscience
LEXX stock →Lexaria Bioscience Corp. operates as a biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
About Exicure
XCUR stock →Exicure, Inc. does not have significant operations.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
LEXX vs XCUR FAQ
Which is bigger, Lexaria Bioscience or Exicure?
Lexaria Bioscience (LEXX) is larger, with a market capitalization of $6.99M compared with $6.87M for Exicure (XCUR).
Are Lexaria Bioscience and Exicure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.